Scheme

Motilal Oswal Nifty MidSmall Healthcare Index Fund

Holds 30 companies worth ₹52.6 Cr in Sept 2026.

Fund house
Motilal OswalThe fund house that runs this scheme.
AUM
₹52.5 CrMotilal Oswal Nifty MidSmall Healthcare Index Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 3.4% on Aug 2026, ₹50.8 Cr.
Largest holding
Laurus Labs LimitedLaurus Labs Limited is 11.8% of this scheme's NAV.
Fund manager
Not available yetIts fund house hasn't published who runs it in a document we can read, so we don't have it yet. Know who runs it? Tell us on its Summary tab.

Holdings^{(Nov 2024 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	30 companies ·	₹ Cr
	Laurus Labs Limited	6.2
	Lupin	4
	Aurobindo Pharma	3.7
	Fortis Healthcare Limited	3.2
	Glenmark Pharmaceuticals	2.8
	Alkem Laboratories Limited	2.5
	Mankind Pharma Limited	2.3
	IPCA Laboratories Limited	2.2
	Biocon	2.1
	Gland Pharma Limited	1.9
	Sai Life Sciences Limited	1.7
	Krishna Institute of Medical Science Ltd	1.6
	Aster DM Healthcare Limited	1.5
	Neuland Laboratories Limited	1.5
	Wockhardt	1.4
	Acutaas Chemicals Limited	1.4
	Ajanta Pharmaceuticals Limited	1.3
	Dr Lal Path Labs Limited	1.3
	Abbott India Limited	1.1
	Piramal Pharma Limited	1
	Granules India Limited	1
	Narayana Hrudayalaya Limited	1
	Global Health Limited	0.98
	Onesource Speciality Pharma Ltd	0.97
	GLAXO SMITHKLINE PHARMA	0.92
	Anthem Biosciences Limited	0.75
	Natco Pharma	0.6
	Cohance Lifesciences Limited	0.58
	Syngene International Limited	0.56
	Poly Medicure Limited	0.52

Laurus Labs Limited
Lupin

Market value of each ticked company in Motilal Oswal Nifty MidSmall Healthcare Index Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Laurus Labs Limited	Lupin
Sept 2025	₹1.8 Cr	₹2.6 Cr
Oct 2025	₹2 Cr	₹2.6 Cr
Nov 2025	₹2.2 Cr	₹2.8 Cr
Dec 2025	₹2.3 Cr	₹2.7 Cr
Jan 2026	₹1.9 Cr	₹2.7 Cr
Feb 2026	₹2.2 Cr	₹2.9 Cr
Mar 2026	₹2 Cr	₹3 Cr
Apr 2026	₹2.3 Cr	₹3 Cr
May 2026	₹3.1 Cr	₹3.2 Cr
Jun 2026	₹3.7 Cr	₹3.7 Cr
Jul 2026	₹5 Cr	₹4.2 Cr
Aug 2026	₹5.7 Cr	₹4.1 Cr
Sept 2026	₹6.2 Cr	₹4 Cr

Fig. 1.Market value of each ticked company in Motilal Oswal Nifty MidSmall Healthcare Index Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Mid Cap	15	67.87

Small Cap	15	32.20

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	31.4K	6.2	11.83
Lupin	Equity	Pharmaceuticals & Biotechnology	19.6K	4	7.57
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	22.3K	3.7	7.09
Fortis Healthcare Limited	Equity	Healthcare Services	42K	3.2	6.15
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	12.1K	2.8	5.39
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	4.86K	2.5	4.78
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	9.13K	2.3	4.35
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	11.2K	2.2	4.11
Biocon	Equity	Pharmaceuticals & Biotechnology	56.2K	2.1	3.96
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	6.42K	1.9	3.54
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	11.1K	1.7	3.23
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	21.5K	1.6	3.06
Aster DM Healthcare Limited	Equity	Healthcare Services	21.5K	1.5	2.86
Neuland Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	695	1.5	2.82
Wockhardt	Equity	Pharmaceuticals & Biotechnology	6.66K	1.4	2.68
Acutaas Chemicals Limited	Equity	Pharmaceuticals & Biotechnology	4.18K	1.4	2.61
Ajanta Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	3.67K	1.3	2.53
Dr Lal Path Labs Limited	Equity	Healthcare Services	6.29K	1.3	2.38
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	420	1.1	2.17
Piramal Pharma Limited	Equity	Pharmaceuticals & Biotechnology	50.1K	1	1.97
Granules India Limited	Equity	Pharmaceuticals & Biotechnology	11.9K	1	1.92
Narayana Hrudayalaya Limited	Equity	Healthcare Services	5.57K	1	1.90
Global Health Limited	Equity	Healthcare Services	7.14K	0.98	1.86
Onesource Speciality Pharma Ltd	Equity	Pharmaceuticals & Biotechnology	6.34K	0.97	1.84
GLAXO SMITHKLINE PHARMA	Equity	Pharmaceuticals & Biotechnology	3.34K	0.92	1.76
Anthem Biosciences Limited	Equity	Pharmaceuticals & Biotechnology	8.7K	0.75	1.42
Natco Pharma	Equity	Pharmaceuticals & Biotechnology	7.24K	0.6	1.14
Cohance Lifesciences Limited	Equity	Pharmaceuticals & Biotechnology	13.1K	0.58	1.11
Syngene International Limited	Equity	Healthcare Services	15.3K	0.56	1.06
Poly Medicure Limited	Equity	Healthcare Equipment & Supplies	3.08K	0.52	0.98

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.